Log In
Print
BCIQ
Print
Print this Print this
 

BM32

  Manage Alerts
Collapse Summary General Information
Company Biomay AG
DescriptionRecombinant peptide-carrier fusion protein vaccine against grass pollen allergens
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPhase II
Standard IndicationAllergy
Indication DetailsTreat grass pollen allergy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today